Video

Giving a Voice to Patients With GI Cancers

Author(s):

Martha Raymond

Martha Raymond, founder and CEO of the Raymond Foundation, discusses how her organization helps to provide a voice for patients with gastrointestinal (GI) cancers.

Martha Raymond, founder and CEO of the Raymond Foundation, discusses how her organization helps to provide a voice for patients with gastrointestinal (GI) cancers.

After losing both her parents to colon cancer, Raymond founded the Raymond Foundation to provide outreach and support to patients with the disease.

Now, the Raymond Foundation serves patients with all kinds of GI cancers by going into the communities and talking to patients and caregivers to better understand what needs they feel are being unmet. The foundation then takes that information to universities, hospitals and medical centers, where larger programs can be established to address these needs.

Related Videos
Dr. Azka Ali is a medical oncologist at the Cleveland Clinic Taussig Cancer Institute, in Ohio.
Dr. Michael Bogenschutz
Photo credit: Max Mumby/Indigo via Getty Images
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine, in the Department of Medicine, at Beth Israel Deaconess Medical Center in Boston.
Dr. Stephanie Alice Baker
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Dr. Laura Dawson, a professor and chair of the department of Radiation Oncology at the University of Toronto, and a practicing radiation oncologist in the Radiation Medicine Program at Princess Margaret Cancer Center, University Health Network in Toronto.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,
Related Content
Image of man with grey hair.
January 16th 2025

An Expert Breaks Down the Meaning of MRD Testing in Cancer Care

Ryan Scott
Dr. Christopher R. Flowers delved into the meaning of MRD, discussing different ways that it may be tested for in patients with various types of cancer.
Identifying and Addressing the Barriers to Clinical Trial Access
January 21st 2021

Identifying and Addressing the Barriers to Clinical Trial Access

Jessica Skarzynski
This week on the “CURE® Talks Cancer” podcast, we spoke with Martha Raymond, of The Raymond Foundation, about how providers can ensure patient safety to increase trial enrollment during the COVID-19 pandemic, and what she and her colleagues are doing to provide better trial access to all patients with cancer.
Image of woman with blondish hair.
December 30th 2024

Empowering Patients With Cancer Through Clear Clinical Trial Communication

Darlene Dobkowski, MA
A clinical trial manager emphasizes the importance of a phased approach to educating patients about complex protocols and potential side effects.
Site Logo
November 15th 2018

The Ins and Outs of Cancer Caregiving

Brielle Benyon
Two women discuss their experience in cancer caregiving, while giving advice to others.
Image of a woman with brown hair smiling.
December 23rd 2024

Ways to Organize Medical Bills During Cancer

Ashley Chan
Utilizing tools such as spreadsheet trackers can make a big difference when organizing cancer-related medical bills and noting out-of-pocket maximums.
Image of a smiling woman with brown hair.
December 20th 2024

How to Self Advocate When Insurance Says No to Cancer Treatment Coverage

Ashley Chan
When insurance denies coverage of cancer treatment, patients with cancer don’t need to take no for an answer, an expert explained.